Stock Price

Veteran investor Stephen Riddell partners with Gallatin Point to launch DS2 Capital, a new firm poised to navigate the complex structured credit market.

Colombier Acquisition Corp. III, with a board of political and tech heavyweights, has a $299M war chest. Its hunt for a 'patriotic' target begins.

With a major rate hike approved and unprecedented demand looming, all eyes are on IDACORP's upcoming Q4 results and its ambitious vision for the West.

A new report reveals a grim reality: the typical American worker has under $1,000 for retirement. Is the system, not the saver, fundamentally broken?

With a $375M facility from Eldridge, Atlas Energy is pivoting from proppant to power, aiming to solve the Permian Basin's growing energy crisis.

The investment giant posted a record $129 billion in annual fundraising, but a slight miss on quarterly earnings sent its stock tumbling.

Magna Mining unveils its 2026 plan, detailing strong production targets for McCreedy West while advancing the ambitious revival of two historic mines.

Barrick Mining unveils a massive dividend hike and a new cash-return policy, but a surprising market dip raises questions about its future outlook.

Despite currency woes and a tough market, the access solutions giant posts record sales and income, fueled by strategic acquisitions and innovation.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Canfor Pulp and Canfor Corp prepare for a critical joint earnings call on March 6 after a year of steep losses and severe market headwinds.

Forum Energy Technologies has extended its $250M credit facility to 2031, a move that strengthens its balance sheet and fuels its 'FET 2030' growth plans.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

Life sciences giant QIAGEN defies economic headwinds with strong 2025 results, signaling aggressive growth in single-cell analysis and bioinformatics.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

DHI Group announces a $10M stock buyback, a bold move showing faith in its strategy as it navigates a complex, AI-driven tech recruitment landscape.

With its lead drug MOLBREEVI under FDA review, Savara's upcoming investor talks are a critical test of its path from clinical trials to market.

IUOE Local 150 backs Speaker Welch for State Central Committeeperson, signaling a major power play in Illinois Democratic politics post-Danny Davis.

The tech giant's savvy financial moves are set to save $27M annually, extending maturities and freeing up cash for future innovation and growth.

The frozen potato giant appoints an AB InBev veteran as Executive Chair and a new CFO, signaling a major push for global expansion and shareholder value.